Motor Neuron Disease Clinical Trials

32 recruitingLast updated: June 18, 2026

There are 32 actively recruiting motor neuron disease clinical trials across 20 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Sheffield, United Kingdom, Edinburgh, United Kingdom, Bethesda, Maryland, United States. Updated daily from ClinicalTrials.gov.


Motor Neuron Disease Trials at a Glance

32 actively recruiting trials for motor neuron disease are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Sheffield, Edinburgh, and Bethesda. Lead sponsors running motor neuron disease studies include Synchron, Inc., National Institute of Neurological Disorders and Stroke (NINDS), and Istituto Auxologico Italiano.

Browse motor neuron disease trials by phase

Treatments under study

About Motor Neuron Disease Clinical Trials

Looking for clinical trials for Motor Neuron Disease? There are currently 30 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Motor Neuron Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Motor Neuron Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 32 trials

Recruiting
Not Applicable

Functional Outcomes and Control Using Synchron BCI - Australia

Neurologic DisorderMotor Neuron DiseaseMotor Neuron Disease / Amyotrophic Lateral Sclerosis+4 more
Synchron, Inc.10 enrolled1 locationNCT07533903
Recruiting
Not Applicable

Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

Motor Neuron DiseaseInherited NeuropathiesInherited Neuromuscular Conditions+1 more
National Institute of Neurological Disorders and Stroke (NINDS)275 enrolled1 locationNCT01900132
Recruiting
Not Applicable

Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.

Amyotrophic Lateral Sclerosis(ALS)Motor Neuron Disease / Amyotrophic Lateral SclerosisPrimary Lateral Sclerosis (PLS)
Nova Southeastern University10 enrolled1 locationNCT07187388
Recruiting
Not Applicable

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

ALSMotor Neuron DiseaseNeurological Disorder+1 more
Synchron, Inc.10 enrolled5 locationsNCT07543367
Recruiting
Not Applicable

Non-invasive BCI-controlled Assistive Devices

Traumatic Brain InjuryHealthyMovement Disorders+6 more
University of Texas at Austin100 enrolled1 locationNCT05183152
Recruiting
Not Applicable

Functional Outcomes and Control Using Synchron BCI - Canada

Neurologic DisorderALSMotor Neuron Disease
Synchron, Inc.10 enrolled2 locationsNCT07446114
Recruiting

Study of Inherited Neurological Disorders

Peripheral nervous system diseaseMotor Neuron DiseaseMuscular Dystrophy+1 more
National Institute of Neurological Disorders and Stroke (NINDS)3,500 enrolled2 locationsNCT00004568
Recruiting

Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth

Amyotrophic Lateral SclerosisMotor Neuron Disease
TidalHealth, Inc.30 enrolled1 locationNCT07491484
Recruiting

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

Movement DisordersMotor Neuron DiseaseHereditary Spastic Paraplegia+3 more
Boston Children's Hospital200 enrolled1 locationNCT05354622
Recruiting

Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

Motor Neuron DiseaseSpinal and Bulbar Muscular AtrophyKennedys Disease
National Institute of Neurological Disorders and Stroke (NINDS)70 enrolled1 locationNCT04944940
Recruiting
Phase 2Phase 3

Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial

Motor Neuron Disease / Amyotrophic Lateral Sclerosis
University of Edinburgh1,150 enrolled22 locationsNCT04302870
Recruiting

Healing ALS Registry Observational Study (HAROS)

Amyotrophic Lateral Sclerosis(ALS)Motor Neuron Disease (MND)Primary Lateral Sclerosis (PLS)
Healing Advocates Registry and Ministry1,000 enrolled1 locationNCT07233148
Recruiting

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Movement DisordersAmyotrophic Lateral SclerosisDegenerative Disorder+1 more
Target ALS Foundation, Inc.1,000 enrolled12 locationsNCT05137665
Recruiting

Digital App for Speech & Health Monitoring

DementiaMultiple SclerosisParkinson Disease+1 more
University of Edinburgh150 enrolled1 locationNCT06450418
Recruiting
Not Applicable

Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families

Amyotrophic Lateral SclerosisNervous System DiseasesSpinal Cord Diseases+3 more
Haukeland University Hospital200 enrolled9 locationsNCT05744310
Recruiting
Not Applicable

GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

QuadriplegiaSpinal Cord InjuryMotor Neuron Disease+6 more
Neuralink Corp7 enrolled2 locationsNCT07127172
Recruiting
Not Applicable

UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

QuadriplegiaSpinal Cord InjuryMotor Neuron Disease+6 more
Neuralink Corp10 enrolled1 locationNCT06992596
Recruiting

Motor Neuron Disease Surveillance Unit in New South Wales

Amyotrophic Lateral SclerosisMotor Neuron Disease
Macquarie University24 enrolled1 locationACTRN12625000427471
Recruiting

Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases

Amyotrophic Lateral SclerosisMotor Neuron Disease
Istituto Auxologico Italiano200 enrolled1 locationNCT06318585
Recruiting

Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral SclerosisMotor Neuron Disease
Istituto Auxologico Italiano200 enrolled3 locationsNCT06318598